×
XWELL Receivables 2010-2024 | XWEL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
XWELL receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company
View More
XWELL Receivables 2010-2024 | XWEL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
XWELL receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$93.4B
Cencora (COR)
$48.3B
DiDi Global (DIDIY)
$22.2B
Natera (NTRA)
$22.1B
ICON (ICLR)
$17.7B
Viatris (VTRS)
$16B
Avantor (AVTR)
$14.1B
Revvity (RVTY)
$13.6B
CochLear (CHEOY)
$12.8B
Solventum (SOLV)
$12.2B
BioMerieux (BMXMF)
$11.9B
Medpace Holdings (MEDP)
$10.5B
Charles River Laboratories (CRL)
$10B
HealthEquity (HQY)
$9.1B
Doximity (DOCS)
$9B
Sonic Healthcare (SKHHY)
$8.9B
Bausch + Lomb (BLCO)
$6.9B
Life Times (LTH)
$5.1B
Organon (OGN)
$3.9B
Sotera Health (SHC)
$3.6B
BrightSpring Health Services (BTSG)
$3.3B
Surgery Partners (SGRY)
$2.9B
Concentras Parent (CON)
$2.8B
PACS (PACS)
$2.5B
Alignment Healthcare (ALHC)
$2.3B
Ardent Health Partners (ARDT)
$2.3B
Premier (PINC)
$2.2B
GeneDx Holdings (WGS)
$2.2B
Ryman Healthcare (RYHTY)
$2B
GoodRx Holdings (GDRX)
$1.9B